Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

CAG repeat length in the AR gene is not linked to PCOS risk in Iranian women.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Targeting IL-15 may help treat Alopecia Areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

New genes linked to male pattern baldness were found on chromosome 20p11.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

Three genes linked to the development of trichilemmal cysts were found.

Male-pattern baldness has a weak link to heart disease and some related health conditions.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Genetic discoveries are leading to new treatments for alopecia areata.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hutchinson-Gilford Progeria Syndrome is a rare genetic disorder caused by a specific gene mutation, characterized by aging symptoms and managed by monitoring heart health and using low-dose aspirin.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Using special RNA to target a mutant gene fixed hair problems in mice.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.